Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants.
Journal
Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509
Informations de publication
Date de publication:
20 06 2019
20 06 2019
Historique:
received:
12
09
2018
accepted:
12
03
2019
pubmed:
25
3
2019
medline:
10
1
2020
entrez:
24
3
2019
Statut:
ppublish
Résumé
Calreticulin (CALR) +1 frameshift mutations in exon 9 are prevalent in myeloproliferative neoplasms. Mutant CALRs possess a new C-terminal sequence rich in positively charged amino acids, leading to activation of the thrombopoietin receptor (TpoR/MPL). We show that the new sequence endows the mutant CALR with rogue chaperone activity, stabilizing a dimeric state and transporting TpoR and mutants thereof to the cell surface in states that would not pass quality control; this function is absolutely required for oncogenic transformation. Mutant CALRs determine traffic via the secretory pathway of partially immature TpoR, as they protect N117-linked glycans from further processing in the Golgi apparatus. A number of engineered or disease-associated TpoRs such as TpoR/MPL R102P, which causes congenital thrombocytopenia, are rescued for traffic and function by mutant CALRs, which can also overcome endoplasmic reticulum retention signals on TpoR. In addition to requiring
Identifiants
pubmed: 30902807
pii: S0006-4971(20)42473-5
doi: 10.1182/blood-2018-09-874578
doi:
Substances chimiques
Calreticulin
0
Molecular Chaperones
0
Receptors, Thrombopoietin
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2669-2681Subventions
Organisme : Austrian Science Fund FWF
ID : P 30041
Pays : Austria
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2019 by The American Society of Hematology.